Issue Date | Title | Author(s) |
2019 | Carbamylated darbepoetin in combination with ethoxydol attenuates doxorubicin-induced cardiomyopathy in rats | Kolesnichenko, P. D.; Popova, I. A.; Sheblykin, D. V.; Alhamzah Muhi Aldeen Azeez; Soldatov, V. O.; Lazareva, G. A.; Stepchenko, A. A. |
2015 | Correction of adma-induced preeclampsia with the use of phosphodiesterase 5 and selective inhibitor of arginase II ZB49-0010 | Gureev, V. V.; Pokrovskii, M. V.; Korokin, M. V.; Gudyrev, O. S.; Philippova, O. V.; Dolzhikov, A. A.; Lazareva, G. A. |
2018 | Correction of morphofunctional disturbances arising when modelling Preeclampsia with resveratrol and nicorandil | Stupakova, E. G.; Lazareva, G. A.; Gureev, V. V. |
2017 | Efficacy and safety of pharmacological treatment of the with clinically apparent bacteriuria and asymptomatic bacteriuria in the pregnant women | Likhikh, D. G.; Lazareva, G. A. |
2020 | Endothelial protective properties of short-chain peptides that mimic α-helix B of erythropoietin in experimental preeclampsia | Golubev, I. V.; Gureev, V. V.; Korokin, M. V.; Gureeva, A. V.; Polyanskaya, A. V.; Pokrovskii, M. V.; Lazareva, G. A.; Bystrova, N. A. |
2016 | Endothelio- and cardioprotective effects of vitamin B₆ and folic acid in modelling methionine-induced hyperhomocysteinemia | Provotorov, V. Y.; Korokin, M. V.; Pokrovskii, M. V.; Povetkin, S. V.; Lazareva, G. A. |
2016 | Endothelium and cardioprotective effects of hmg-co-a-reductase in combination with l-arginine In endothelial dysfunction modeling | Denisyuk, T. A.; Lazareva, G. A.; Provotorov, V. Y.; Shaposhnikov, A. A. |
2016 | Influence of phosphocreatine on mitochondrial activity in patients with angina pectoris | Romaschenko, O. V.; Nikolaev, S. B.; Stepchenko, A. A.; Zhernakova, N. I.; Lazareva, G. A. |
2019 | L-NAME-induced preeclampsia: correction of functional disorders of the hemostasis system with resveratrol and nicorandil | Stupakova, E. G.; Lazareva, G. A.; Gureev, V. V.; Dolzhikova, I. N.; Zhilinkova, L. A. |
2017 | Lipid distress-syndrome and prospects of its correction by statines | Denisiuk, T. A.; Lazareva, G. A.; Provotorov, V. Y. |
2017 | Pharmacological correction of fetoplacental insufficiency with fetal growth retardation syndrome | Klycheva, O. I.; Lazareva, G. A.; Khuraseva, A. B. |
2016 | Pharmacotherapy exacerbations of chronic inflammatory conditions of female genital sphere using to Gepon and Longidaza | Abramova, S. N.; Lazareva, G. A. |
2019 | Study of the effect of selective inhibitor of arginase II KUD 975 and of low doses of acetylsalicylic acid on the functional parameters of the cardiovascular system In experimental preeclampsia | Severinova, O. V.; Gureev, V. V.; Zhilinkova, L. A.; Lazareva, G. A.; Gureeva, A. V. |
2019 | The research of abnormal toxicity and local irritant effect in the Draize test of the drug furacilin, concentrate for the preparation of a solution for local and externaluse | Pobeda, A. S.; Miller, E. S.; Soldatov, V. O.; Lazareva, G. A.; Reznikov, K. M.; Sernov, L. N.; Yakovleva, E. G.; Reznichenko, L. V.; Faitelson, A. V. |